Tarrant to Oversee Strategic Growth Initiatives and Drive Market Adoption of Asset-Centric Development Model ROCKVILLE, Md., April 5 /PRNewswire/ -- RRD International, a strategy-driven biotech and pharmaceutical product development company, announced today that J.

ANDOVER, Mass., Jan. 5 /PRNewswire-FirstCall/ -- MKS Instruments, Inc. (Nasdaq: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced several changes in management which are effective immediately. Gerald G.

BERLIN, NIMES, France and RICHMOND, Calif., June 22 /PRNewswire/ -- BRAHMS Aktiengesellschaft, a global diagnostics company, Cezanne, and Lumiphore Inc., a biotechnology leader in new proprietary fluorescent metal-lanthanide technology for use in high-value applications, announced that they have signed an agreement on incorporation of Lumiphore's Lumi4(R)-Tb complexes in BRAHMS diagnostic tests. Under the agreement, BRAHMS together with its subsidiary Cezanne, developer and manufacturer of KRYPTOR automated diagnostic solutions, has the non-exclusive rights to incorporate Lumi4(R) technology into current and future diagnostic tests and the exclusive rights to use the technology in diagnostic tests for Down's Syndrome including Trisomy 21, 13 and 18, Triploidy, Translocation, and Mosaicism. "Lumiphore's goal is to bring the benefits of lanthanide-based homogenous assays to the diagnostic markets, from central labs to point-of-care applications.

NOTTINGHAM, England, October 1 /PRNewswire/ -- Critical Pharmaceuticals, the Nottingham, UK-based speciality pharmaceuticals company, today announced that the successful completion of preclinical trials of a sustained release formulation of the synthetic human growth hormone (hGH) somatropin.

PALO ALTO, Calif., June 14 /PRNewswire/ -- Anacor Pharmaceuticals, a privately held pharmaceutical company, announced today it has hired Paulette A. Dillon as its chief business officer. In that post, Ms. Dillon will be responsible for overseeing commercial and business development.